Goldman Capital Management’s PURE BIOSCIENCE INC COM STK NEW (DE) PURE Stock Holding History

Goldman Capital Management’s Portfolio PURE Stock Details PURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$156K	Hold	163,884	–	–	0.15%	24
2017 Q3	$166K	Hold	163,884	–	–	0.16%	20
2017 Q2	$187K	Sell	163,884 -229,366	-58%	-$262K	0.2%	22
2017 Q1	$405K	Sell	393,250 -43,278	-10%	-$44.6K	0.39%	22
2016 Q4	$380K	Sell	436,528 -442,656	-50%	-$385K	0.33%	20
2016 Q3	$958K	Sell	879,184 -130,000	-13%	-$142K	0.77%	18
2016 Q2	$1.06M	Buy	1,009,184 +236,951	+31%	+$249K	0.91%	18
2016 Q1	$880K	Buy	772,233 +542,233	+236%	+$618K	0.67%	19
2015 Q4	$221K	Hold	230,000	–	–	0.17%	24
2015 Q3	$168K	Sell	230,000 -10,000	-4%	-$7.3K	0.12%	26
2015 Q2	$175K	Sell	240,000 -10,000	-4%	-$7.29K	0.11%	29
2015 Q1	$160K	Buy	+250,000	New	+$160K	0.09%	31

Other funds holding PURE

VCM

Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return

Goldman Capital Management's PURE Position: Q4 2017 in Review

Goldman Capital Management held its PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) position steady in Q4 2017 at 163,884 shares worth $156K. The position accounts for 0.15% of the portfolio, ranked #24.

Goldman Capital Management first reported a position in PURE in Q1 2015 and has held it in 12 quarters since. The position peaked at $1.06M in Q2 2016. 2 funds tracked by Wall St. Rank hold PURE as of Q4 2017.

Goldman Capital Management held 163,884 shares of PURE BIOSCIENCE INC COM STK NEW (DE) worth $156K as of Q4 2017.
Goldman Capital Management left its PURE BIOSCIENCE INC COM STK NEW (DE) share count unchanged in Q4 2017.
PURE BIOSCIENCE INC COM STK NEW (DE) made up 0.15% of Goldman Capital Management's portfolio in Q4 2017, its #24 holding.
Goldman Capital Management first reported a position in PURE BIOSCIENCE INC COM STK NEW (DE) in Q1 2015 and has held it in 12 quarters since.
Goldman Capital Management's PURE BIOSCIENCE INC COM STK NEW (DE) position peaked at $1.06M in Q2 2016.
2 funds tracked by Wall St. Rank held PURE BIOSCIENCE INC COM STK NEW (DE) as of Q4 2017.

Based on Goldman Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.